Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Colorcon
Dow
Boehringer Ingelheim
Express Scripts

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Litigation Details for Guardant Health, Inc. v. Foundation Medicine, Inc. (D. Del. 2017)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Guardant Health, Inc. v. Foundation Medicine, Inc. (D. Del. 2017)

Small Molecule Drugs cited in Guardant Health, Inc. v. Foundation Medicine, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Guardant Health, Inc. v. Foundation Medicine, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2020-05-07 432 Report and Recommendations Infringement of All Patents-in-Suit and Invalidity of U.S. Patent No. 9,840,743 filed by Personal Genome…Theories filed by Personal Genome Diagnostics, Inc., (463 in 1:17-cv-01623-LPS-CJB) MOTION to Strike Personal…no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further… 9 November 2017 1:17-cv-01616 830 Patent Both District Court, D. Delaware External link to document
2020-05-15 437 Redacted Document .]” (See, e.g., '822 patent, col. 62:44-46; '992 patent, col. 64:32-34) The parties’ dispute… the patent specification[.]” Univ. of Rochester v. G.D. Searle & Co., 358 F.3d 916, 920 (Fed.…predefined regions is a single base.” ('743 patent, col. 64:29-30) Guardant asserts that “[i]f the … tagged parent polynucleotides,” ('992 patent, col. 64:16-18 (emphasis added)), which the …least 20% of the cfDNA molecules[.]” ('992 patent, col. 64:6-8) Claim 12 depends from claim 1 and External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
McKinsey
Moodys
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.